ITM Isotope Technologies Munich Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 607

Employees

  • Latest Deal Type
  • M&A
  • (Announced)

  • Financing Rounds
  • 12

  • Investments
  • 3

ITM Isotope Technologies Munich General Information

Description

Manufacturer of medical radioisotopes designed for precision oncology applications. The company offers non-carrier-added lutetium-177, actinium-225, gallium-68, automated theranostics synthesizers, radiopharmaceutical conjugates, and medical radioisotopes, providing oncology centers with targeted diagnostic and therapeutic tools to improve patient outcomes.

Contact Information

Formerly Known As
ITM Isotopen Technologien München Aktiengesellschaft
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Walther-von-Dyck-Strasse 4
  • 85748 Munich
  • Germany
+49 089
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • Walther-von-Dyck-Strasse 4
  • 85748 Munich
  • Germany
+49 089

ITM Isotope Technologies Munich Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ITM Isotope Technologies Munich Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ITM Isotope Technologies Munich‘s full profile, request access.

Request a free trial

ITM Isotope Technologies Munich Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of medical radioisotopes designed for precision oncology applications. The company offers non-carrier-added
Biotechnology
Munich, Germany
607 As of 2025

Sydney, Australia
 

Columbus, OH
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ITM Isotope Technologies Munich Competitors (53)

One of ITM Isotope Technologies Munich’s 53 competitors is Kazia Therapeutics, a Corporation company based in Sydney, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kazia Therapeutics Corporation Sydney, Australia
Navidea Biopharmaceuticals Corporate Backed or Acquired Columbus, OH
RadioMedix Venture Capital-Backed Houston, TX
Bridge Medicines Venture Capital-Backed New York, NY
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 53 competitors. Get the full list »

ITM Isotope Technologies Munich Patents

ITM Isotope Technologies Munich Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4822714-A1 68ge/68ga generator Pending 08-Apr-2025
WO-2026215071-A1 68ge/68ga generator Pending 08-Apr-2025
EP-4763231-A1 Para-aminohippuric acid as a stabilizer in radiopharmaceutical compositions Pending 20-Dec-2024
WO-2026133265-A1 Para-aminohippuric acid as a stabilizer in radiopharmaceutical compositions Pending 20-Dec-2024
AU-2025259463-A1 Stable formulations comprising 225-actinium labeled complexes and methods for preparing the same Pending 15-Apr-2024 A61K51/0497
To view ITM Isotope Technologies Munich’s complete patent history, request access »

ITM Isotope Technologies Munich Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ITM Isotope Technologies Munich Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ITM Isotope Technologies Munich‘s full profile, request access.

Request a free trial

ITM Isotope Technologies Munich Investments (3)

ITM Isotope Technologies Munich’s most recent deal was a Joint Venture with Actineer. The deal was made on 18-Oct-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Actineer 18-Oct-2023 Joint Venture Monitoring Equipment
Positron Precision 18-Aug-2022 Buyout/LBO Other Healthcare Technology Systems
Joint Venture (Chengdu Gaotong Isotope / ITM) 13-Sep-2021 Joint Venture Drug Discovery
To view ITM Isotope Technologies Munich’s complete investments history, request access »

ITM Isotope Technologies Munich Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Silk Road Precision Oncologics Garching Bei Munchen, Germany 2017
Itg Alpha Garching Bei Munchen, Germany 2017

ITM Isotope Technologies Munich FAQs

  • When was ITM Isotope Technologies Munich founded?

    ITM Isotope Technologies Munich was founded in 2004.

  • Where is ITM Isotope Technologies Munich headquartered?

    ITM Isotope Technologies Munich is headquartered in Munich, Germany.

  • What is the size of ITM Isotope Technologies Munich?

    ITM Isotope Technologies Munich has 607 total employees.

  • What industry is ITM Isotope Technologies Munich in?

    ITM Isotope Technologies Munich’s primary industry is Biotechnology.

  • Is ITM Isotope Technologies Munich a private or public company?

    ITM Isotope Technologies Munich is a Private company.

  • What is the current valuation of ITM Isotope Technologies Munich?

    The current valuation of ITM Isotope Technologies Munich is .

  • What is ITM Isotope Technologies Munich’s current revenue?

    The current revenue for ITM Isotope Technologies Munich is .

  • How much funding has ITM Isotope Technologies Munich raised over time?

    ITM Isotope Technologies Munich has raised $878M.

  • Who are ITM Isotope Technologies Munich’s investors?

    Petrichor Healthcare Capital Management, RV Invest, Serial Stage Venture Partners, Athos (Family Office), and BlackRock are 5 of 14 investors who have invested in ITM Isotope Technologies Munich.

  • Who are ITM Isotope Technologies Munich’s competitors?

    Kazia Therapeutics, Navidea Biopharmaceuticals, RadioMedix, Bridge Medicines, and Genentech are some of the 53 competitors of ITM Isotope Technologies Munich.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process